APO RESEARCH · REPORT
Montelukast Sodium
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Product & engineering
Understand the product.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Selected research
Industry Research
Montelukast Sodium Industry Research Report 2026
Market perspective
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
Report Scope
Read the full market overview
This report quantifies the global Montelukast Sodium market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Montelukast Sodium.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Montelukast Sodium Market by Company
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Montelukast Sodium Segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Montelukast Sodium Segment by Application
Tablets
Chewable Tablet
Oral Solution
Montelukast Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Montelukast Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Montelukast Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Montelukast Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Montelukast Sodium Amorphous
- Montelukast Sodium Crystalline
Applications
- Tablets
- Chewable Tablet
- Oral Solution
Companies covered
- Morepen Laboratories
- Mylan
- TAPI
- MSN Laboratories
- Ultratech India
- Aurobindo Pharma
- Hetero Labs
- Unimark Remedies
- Jubilant Cadista
- Aamorb Pharmaceuticals
- Sudarshan Group
- Ortin Laboratories
- Vamsi Labs
- Adley Group
- Medopharm
- Hengyuan Pharmaceutical
- Arromax Pharmaceutical Technology
- Lihe Wuhan New Chemical Materials
- Shanghai Huachu Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Montelukast Sodium by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Montelukast Sodium Amorphous
- 2.2.3 Montelukast Sodium Crystalline
- 2.3 Montelukast Sodium by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Chewable Tablet
- 2.3.4 Oral Solution
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Montelukast Sodium Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Montelukast Sodium Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Montelukast Sodium Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Montelukast Sodium Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Montelukast Sodium Production by Manufacturers (2021-2026)
- 3.2 Global Montelukast Sodium Production Value by Manufacturers (2021-2026)
- 3.3 Global Montelukast Sodium Average Price by Manufacturers (2021-2026)
- 3.4 Global Montelukast Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Montelukast Sodium Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Montelukast Sodium Manufacturers, Product Type & Application
- 3.7 Global Montelukast Sodium Manufacturers Established Date
- 3.8 Global Montelukast Sodium Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Morepen Laboratories
- 4.1.1 Morepen Laboratories Montelukast Sodium Company Information
- 4.1.2 Morepen Laboratories Montelukast Sodium Business Overview
- 4.1.3 Morepen Laboratories Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Morepen Laboratories Product Portfolio
- 4.1.5 Morepen Laboratories Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Montelukast Sodium Company Information
- 4.2.2 Mylan Montelukast Sodium Business Overview
- 4.2.3 Mylan Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Mylan Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 TAPI
- 4.3.1 TAPI Montelukast Sodium Company Information
- 4.3.2 TAPI Montelukast Sodium Business Overview
- 4.3.3 TAPI Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 TAPI Product Portfolio
- 4.3.5 TAPI Recent Developments
- 4.4 MSN Laboratories
- 4.4.1 MSN Laboratories Montelukast Sodium Company Information
- 4.4.2 MSN Laboratories Montelukast Sodium Business Overview
- 4.4.3 MSN Laboratories Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 MSN Laboratories Product Portfolio
- 4.4.5 MSN Laboratories Recent Developments
- 4.5 Ultratech India
- 4.5.1 Ultratech India Montelukast Sodium Company Information
- 4.5.2 Ultratech India Montelukast Sodium Business Overview
- 4.5.3 Ultratech India Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Ultratech India Product Portfolio
- 4.5.5 Ultratech India Recent Developments
- 4.6 Aurobindo Pharma
- 4.6.1 Aurobindo Pharma Montelukast Sodium Company Information
- 4.6.2 Aurobindo Pharma Montelukast Sodium Business Overview
- 4.6.3 Aurobindo Pharma Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Aurobindo Pharma Product Portfolio
- 4.6.5 Aurobindo Pharma Recent Developments
- 4.7 Hetero Labs
- 4.7.1 Hetero Labs Montelukast Sodium Company Information
- 4.7.2 Hetero Labs Montelukast Sodium Business Overview
- 4.7.3 Hetero Labs Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Hetero Labs Product Portfolio
- 4.7.5 Hetero Labs Recent Developments
- 4.8 Unimark Remedies
- 4.8.1 Unimark Remedies Montelukast Sodium Company Information
- 4.8.2 Unimark Remedies Montelukast Sodium Business Overview
- 4.8.3 Unimark Remedies Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Unimark Remedies Product Portfolio
- 4.8.5 Unimark Remedies Recent Developments
- 4.9 Jubilant Cadista
- 4.9.1 Jubilant Cadista Montelukast Sodium Company Information
- 4.9.2 Jubilant Cadista Montelukast Sodium Business Overview
- 4.9.3 Jubilant Cadista Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Jubilant Cadista Product Portfolio
- 4.9.5 Jubilant Cadista Recent Developments
- 4.10 Aamorb Pharmaceuticals
- 4.10.1 Aamorb Pharmaceuticals Montelukast Sodium Company Information
- 4.10.2 Aamorb Pharmaceuticals Montelukast Sodium Business Overview
- 4.10.3 Aamorb Pharmaceuticals Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Aamorb Pharmaceuticals Product Portfolio
- 4.10.5 Aamorb Pharmaceuticals Recent Developments
- 4.11 Sudarshan Group
- 4.11.1 Sudarshan Group Montelukast Sodium Company Information
- 4.11.2 Sudarshan Group Montelukast Sodium Business Overview
- 4.11.3 Sudarshan Group Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Sudarshan Group Product Portfolio
- 4.11.5 Sudarshan Group Recent Developments
- 4.12 Ortin Laboratories
- 4.12.1 Ortin Laboratories Montelukast Sodium Company Information
- 4.12.2 Ortin Laboratories Montelukast Sodium Business Overview
- 4.12.3 Ortin Laboratories Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Ortin Laboratories Product Portfolio
- 4.12.5 Ortin Laboratories Recent Developments
- 4.13 Vamsi Labs
- 4.13.1 Vamsi Labs Montelukast Sodium Company Information
- 4.13.2 Vamsi Labs Montelukast Sodium Business Overview
- 4.13.3 Vamsi Labs Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Vamsi Labs Product Portfolio
- 4.13.5 Vamsi Labs Recent Developments
- 4.14 Adley Group
- 4.14.1 Adley Group Montelukast Sodium Company Information
- 4.14.2 Adley Group Montelukast Sodium Business Overview
- 4.14.3 Adley Group Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Adley Group Product Portfolio
- 4.14.5 Adley Group Recent Developments
- 4.15 Medopharm
- 4.15.1 Medopharm Montelukast Sodium Company Information
- 4.15.2 Medopharm Montelukast Sodium Business Overview
- 4.15.3 Medopharm Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Medopharm Product Portfolio
- 4.15.5 Medopharm Recent Developments
- 4.16 Hengyuan Pharmaceutical
- 4.16.1 Hengyuan Pharmaceutical Montelukast Sodium Company Information
- 4.16.2 Hengyuan Pharmaceutical Montelukast Sodium Business Overview
- 4.16.3 Hengyuan Pharmaceutical Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Hengyuan Pharmaceutical Product Portfolio
- 4.16.5 Hengyuan Pharmaceutical Recent Developments
- 4.17 Arromax Pharmaceutical Technology
- 4.17.1 Arromax Pharmaceutical Technology Montelukast Sodium Company Information
- 4.17.2 Arromax Pharmaceutical Technology Montelukast Sodium Business Overview
- 4.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Arromax Pharmaceutical Technology Product Portfolio
- 4.17.5 Arromax Pharmaceutical Technology Recent Developments
- 4.18 Lihe Wuhan New Chemical Materials
- 4.18.1 Lihe Wuhan New Chemical Materials Montelukast Sodium Company Information
- 4.18.2 Lihe Wuhan New Chemical Materials Montelukast Sodium Business Overview
- 4.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.18.4 Lihe Wuhan New Chemical Materials Product Portfolio
- 4.18.5 Lihe Wuhan New Chemical Materials Recent Developments
- 4.19 Shanghai Huachu Chemical
- 4.19.1 Shanghai Huachu Chemical Montelukast Sodium Company Information
- 4.19.2 Shanghai Huachu Chemical Montelukast Sodium Business Overview
- 4.19.3 Shanghai Huachu Chemical Montelukast Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.19.4 Shanghai Huachu Chemical Product Portfolio
- 4.19.5 Shanghai Huachu Chemical Recent Developments
5 Global Montelukast Sodium Production by Region
- 5.1 Global Montelukast Sodium Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Montelukast Sodium Production by Region: 2021-2032
- 5.2.1 Global Montelukast Sodium Production by Region: 2021-2026
- 5.2.2 Global Montelukast Sodium Production Forecast by Region (2027-2032)
- 5.3 Global Montelukast Sodium Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Montelukast Sodium Production Value by Region: 2021-2032
- 5.4.1 Global Montelukast Sodium Production Value by Region: 2021-2026
- 5.4.2 Global Montelukast Sodium Production Value Forecast by Region (2027-2032)
- 5.5 Global Montelukast Sodium Market Price Analysis by Region (2021-2026)
- 5.6 Global Montelukast Sodium Production and Value, YOY Growth
- 5.6.1 North America Montelukast Sodium Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Montelukast Sodium Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Montelukast Sodium Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Montelukast Sodium Production Value Estimates and Forecasts (2021-2032)
6 Global Montelukast Sodium Consumption by Region
- 6.1 Global Montelukast Sodium Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Montelukast Sodium Consumption by Region (2021-2032)
- 6.2.1 Global Montelukast Sodium Consumption by Region: 2021-2026
- 6.2.2 Global Montelukast Sodium Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Montelukast Sodium Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Montelukast Sodium Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Montelukast Sodium Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Montelukast Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Montelukast Sodium Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Montelukast Sodium Production by Type (2021-2032)
- 7.1.1 Global Montelukast Sodium Production by Type (2021-2032) & (Kg)
- 7.1.2 Global Montelukast Sodium Production Market Share by Type (2021-2032)
- 7.2 Global Montelukast Sodium Production Value by Type (2021-2032)
- 7.2.1 Global Montelukast Sodium Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Montelukast Sodium Production Value Market Share by Type (2021-2032)
- 7.3 Global Montelukast Sodium Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Montelukast Sodium Production by Application (2021-2032)
- 8.1.1 Global Montelukast Sodium Production by Application (2021-2032) & (Kg)
- 8.1.2 Global Montelukast Sodium Production Market Share by Application (2021-2032)
- 8.2 Global Montelukast Sodium Production Value by Application (2021-2032)
- 8.2.1 Global Montelukast Sodium Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Montelukast Sodium Production Value Market Share by Application (2021-2032)
- 8.3 Global Montelukast Sodium Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Montelukast Sodium Value Chain Analysis
- 9.1.1 Montelukast Sodium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Montelukast Sodium Production Mode & Process
- 9.2 Montelukast Sodium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Montelukast Sodium Distributors
- 9.2.3 Montelukast Sodium Customers
10 Global Montelukast Sodium Analyzing Market Dynamics
- 10.1 Montelukast Sodium Industry Trends
- 10.2 Montelukast Sodium Industry Drivers
- 10.3 Montelukast Sodium Industry Opportunities and Challenges
- 10.4 Montelukast Sodium Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst